TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evaxion Biotech A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
68
|
0
|
0 |
| Earnings before taxes |
-21,188
|
-22,833
|
-21,572 |
| Total assets |
12,407
|
20,230
|
35,369 |
| Current assets |
7,527
|
14,885
|
29,935 |
| Current liabilities |
7,152
|
3,107
|
3,746 |
| Equity capital |
-4,279
|
7,785
|
28,619 |
| - share capital |
5,085
|
3,246
|
3,120 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-34.5%
|
38.5%
|
80.9% |
| Turnover per employee |
2
|
0
|
0 |
| Profit as a percentage of turnover | -31158.8% | ||
| Return on assets (ROA) | |||
| Current ratio |
105.2%
|
479.1%
|
799.1% |
| Return on equity (ROE) |
495.2%
|
-293.3%
|
-75.4% |
| Change turnover |
68
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.